AUTHOR NAME

AJ

297 POSTS
0 COMMENTS

Cardurion Pharmaceuticals Secures $260 Million Series B Financing to Advance Cardiovascular Therapeutics

Cardurion Pharmaceuticals, a clinical-stage biotechnology company specializing in next-generation cardiovascular therapeutics, has successfully raised $260 million in a Series B financing round. This significant...

New Opioid Design Offers Hope for Pain Relief Without Severe Side Effects

In a study published in ACS Central Science, researchers have unveiled a novel approach to opioid design that promises effective pain relief with fewer...

Legal Battle Intensifies Over 23andMe Data Breach

Attorneys representing genetic testing company 23andMe will convene on Wednesday in Napa Valley for mediation with approximately 20 lawyers from various firms who have...

Danaher Launches New Innovation Centers to Advance Precision Medicine

Danaher Corporation, has announced the establishment of two new Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified laboratories. These labs are...

Global Study Reveals Predictable Patterns in Fungal Biodiversity

In a study published in the journal Nature, an international team of scientists has unveiled the intricate and highly predictable spatial and seasonal dynamics...

Study Demonstrates Superior Accuracy of Real-Time Genomics for Antibiotic Resistance Detection

A study published in Nature reveals that real-time genomics, specifically through nanopore sequencing, can significantly enhance the accuracy of antibiotic resistance predictions in clinical...

Review Highlights Transformative Role of Artificial Intelligence in Genetics

A review article sheds light on the groundbreaking potential of artificial intelligence (AI) in the field of genetics, showcasing how AI technologies are revolutionizing...

New Study Reveals Complex Web of Zoonotic Interactions in Austria

A study recently published in a nature has unveiled the intricate network of zoonotic interactions within Austria, highlighting the critical interfaces where zoonotic diseases...

Illumina Acquires Fluent BioSciences, Expands Single-Cell Technology Capabilities

Illumina, Inc. has announced the acquisition of Fluent BioSciences, a developer of advanced single-cell technology. This strategic move, effective immediately, positions Fluent BioSciences as...

Flagship Pioneering Expands Capital Base by $3.6 Billion to Fuel Breakthrough Innovations

Flagship Pioneering, a prominent bioplatform innovation company, has significantly bolstered its financial foundation, raising an additional $3.6 billion. This infusion of capital is aimed...

Latest news